U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 201820

BETHKIS (TOBRAMYCIN)
300MG/4ML
Marketing Status: Prescription
Active Ingredient: TOBRAMYCIN
Proprietary Name: BETHKIS
Dosage Form; Route of Administration: SOLUTION; INHALATION
Strength: 300MG/4ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AN
Application Number: N201820
Product Number: 001
Approval Date: Oct 12, 2012
Applicant Holder Full Name: CHIESI USA INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top